Skip Navigation

Masks Strongly Recommended but Not Required in Maryland, Starting Immediately

Due to the downward trend in respiratory viruses in Maryland, masking is no longer required but remains strongly recommended in Johns Hopkins Medicine clinical locations in Maryland. Read more.

News & Publications

Newsroom

Covid-19 Story Tip: What’s an Emergency Use Authorization? Johns Hopkins Medicine Expert Explains in Video

12/15/2020

EUA
In news about the new COVID-19 vaccines, the term “emergency use authorization” gets frequently used. But what is an EUA? Johns Hopkins Medicine’s Anita Gupta explains in a 2-minute video. Credit: Graphic created by M.E. Newman, Johns Hopkins Medicine, with background image of SARS-CoV-2 viruses (cause of COVID-19) from National Institute of Allergy and Infectious Diseases and photo of Anita Gupta courtesy of her.

On Dec. 10, 2020, a U.S. Food and Drug Administration advisory committee granted emergency use authorization (EUA) status for a recently developed and clinical trial-tested COVID-19 vaccine to make it available to the public.

In a two-minute video, Anita Gupta, D.O., Pharm.D., M.P.P., an adjunct assistant professor of anesthesiology and critical care medicine and pain medicine at the Johns Hopkins University School of Medicine, explains what an EUA is and how it can help health care workers bring the coronavirus pandemic under control.

Gupta is available for media interviews.